Home
Our Team
The Challenge
The Innovation
News
Contact & Service
News
New shareholder structure
CureDiab at the EASD Annual Meeting 2022
Data about hepatoprotective activity of the positive allosteric GABAA-receptor modulator in lipotoxicity-induced injury published!
Bio International Convention in San Diego from June 13-16, 2022
Curediab at the German Diabetes Congress
CureDiab at the 82nd Scientific Session of the American Diabetes Association (ADA) 2022
CureDiab at the International Conference on Fatty Liver (ICFL) 2022
CureDiabs new website is online
